OVERVIEW

Amid the COVID pandemic, the market for insulin delivery devices is expected to grow over the forecast period at a CAGR of 9.1%. The major drivers on the market include favourable reimbursement scenario and government support in selected countries, developments in insulin delivery systems technology, and increasing diabetic population.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Insulin Delivery Devices Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Insulin Delivery Devices Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Insulin Delivery Devices Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Insulin Delivery Devices Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Insulin Delivery Devices Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Insulin Delivery Devices Market ? By Component (Market Size ? & million/billion)
  • 8.1 Pens
  • 8.2 Pumps
  • 8.3 Pen Needles
  • 8.4 Syringes
  • 8.5 Other

• 9 Global Insulin Delivery Devices Market - By End-User
  • 9.1 Patients/Homecare
  • 9.2 Hospitals & Clinics

• 10 Global Insulin Delivery Devices Market ? By Geography (Market Size ? & million/billion)
  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 U.K
    • 10.3.2 Germany
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 South Korea
    • 10.4.5 Rest of APAC
  • 10.5 Rest of the World
    • 10.5.1 South America
    • 10.5.2 Middle East
    • 10.5.3 Africa

• 11 Global Insulin Delivery Devices Market ? Entropy
  • 11.1 New product launches
  • 11.2 M&A's, collaborations, JVs and partnerships

• 12 Global Insulin Delivery Devices Market Company Profile (Key Players)
  • 12.1 Market Share, Company Revenue, Products, M&A, Developments
  • 12.2 Becton, Dickinson and Company
  • 12.3 Novo Nordisk A/S
  • 12.4 Medtronic PLC
  • 12.5 Animas Corporation (Johnson and Johnson)
  • 12.6 Tandem Diabetes Care, Inc.
  • 12.7 Sanofi
  • 12.8 Insulet Corporation
  • 12.9 ELI Lilly and Company
  • 12.10 Ypsomed Holding AG
  • 12.11 Biocon Limited
  • 12.12 Company 11 & more

• 13 Global Insulin Delivery Devices Market - Appendix
  • 13.1 Sources
  • 13.2 Abbreviations